The HARLINIS brand, founded in 2015 (Sweden), from 585 sister brands and 17478 competing brands. HARLINIS is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. HARLINIS is part of the Drug Manufacturers activity sector.